Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nitya Patanjali"'
Autor:
Catalina A. Palma, Geoffrey Watson, Peter Earls, Nitya Patanjali, Jerome Laurence, Scott Leslie
Publikováno v:
Urology Case Reports, Vol 45, Iss , Pp 102206- (2022)
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare genetic disorder characterised by a germline mutation of the fumarate hydratase (FH) gene, in which affected individuals have a high likelihood of developing cutaneous leiomyomas, uter
Externí odkaz:
https://doaj.org/article/442d77c1fe924025909bd4a024b090c3
Autor:
Patrick Estoesta, Benjamin P. Jonker, Christopher A. Ovens, Benjamin Dean, Michael O'Connor, Nitya Patanjali, Clare L. Fraser, Cecelia Gzell, Tatiana DeMartin
Publikováno v:
Journal of Clinical Neuroscience. 80:162-168
Optic nerve sheath meningiomas (ONSMs) are rare, benign neoplasms of the anterior visual pathway. The optimal modality of radiotherapy for treatment has not yet been established. This is the first study to show significant difference in visual outcom
Publikováno v:
Internal Medicine Journal. 50:771-773
Autor:
Siobhan Ng, Emma Link, Andrew Weickhardt, Laura Galleta, Nitya Patanjali, George Hruby, Ian D. Davis, Nathan Lawrentschuk, Elizabeth Chien Hern Liow, Alan Herschtal, Australia, Peter Grimison, Amanda Seegum, Robert Goodwin, Farshad Foroudi, Colin Chen, Alison Yan Zhang, Margaret McJannett, Elizabeth Hovey, Alexander Guminski, Colin Tang, New Zealand Urogenital
Publikováno v:
Journal of Clinical Oncology. 38:485-485
485 Background: In patients (pts) with muscle invasive bladder (MIBC) suitable for curative definitive chemoradiotherapy (CRT), we hypothesise that the addition of pembrolizumab may be safe and improve efficacy. A pre-planned safety analysis was perf
Publikováno v:
Brachytherapy. 14:670-676
Aims To report disease outcomes and late urinary toxicity profile. To assess the impact of changing technique and evolving quality assurance on genitourinary toxicity rates. Methods and materials One hundred eighty patients were treated with external
Publikováno v:
Asia-Pacific journal of clinical oncology. 13(5)
Aim In prostate cancer, fiducial marker image-guided radiotherapy (FMIGRT) allows correction of setup errors and interfraction physiological motion resulting in improved accuracy of target and sparing of at risk organs. We aim to report outcomes and
Autor:
Deborah Whalley, Mark D. Chatfield, Nitya Patanjali, Michael Jackson, Aimee Lovett, George Hruby
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 56:220-226
Introduction: To report the toxicity and early efficacy of high-dose rate brachytherapy (HDR) as a boost to external beam radiation (EBRT) in the treatment of localised prostate cancer.Methods: Between December 2002 and November 2007, 101 consecutive
Pembrolizumab and chemoradiotherapy for muscle invasive bladder cancer: The ANZUP 1502 PCR-MIB trial
Autor:
Siobhan Ng, Andrew Weickhardt, Colin Chen, Nitya Patanjali, Alan Herschtal, Shomik Sengupta, Tom Jarvis, Robert Goodwin, Ian D. Davis, Farshad Foroudi, Laura Galletta, Shahneen Sandhu, Nathan Lawrentschuk, Elizabeth Hovey, Colin Tang, Keen Hun Tai, Peter Grimison
Publikováno v:
Journal of Clinical Oncology. 36:TPS531-TPS531
TPS531 Background: Pembrolizumab leads to responses in ~20% of metastatic bladder cancer patients. Irradiation of bladder cancer cells in-vitro and in-vivo leads to upregulation of PD-L1, and in immunocompetent mouse models blockade of PD-L1 leads to
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 34
We report a unique case of neurological deficit from late onset multiple sclerosis (MS), in a 65-year-old woman, after stereotactic radiosurgery (SRS) for trigeminal neuralgia (TN). At 3.5months post-SRS for TN, the patient developed ataxia and left
Autor:
Robert Goodwin, S. Leslie, Shahneen Sandhu, C. Chen, Elizabeth Hovey, Farshad Foroudi, Andrew Weickhardt, Siobhan Ng, Nathan Lawrentschuk, Laura Galletta, Shomik Sengupta, T. Jarvis, K.H. Tai, Colin Tang, Alan Herschtal, Nitya Patanjali, Peter Grimison, Ian D. Davis
Publikováno v:
Annals of Oncology. 27:vi294